CCL18 and interstitial lung disease: The molecules worth considering are, among others, matrix metalloproteinase-7 (MMP7), chemokine ligand 18 (CCL18) and YKL-40, which were biomarkers previously studied in IPF and CTD-ILD groups of patients.